What is treatment refractory

What is treatment refractory

[adjective] resisting control or authority :The clinician should examine potential factors contributing to apparent.Refractory epilepsy is a form of epilepsy that does not respond to treatment with medication.However, other treatment options are available.If all relapses after a long remission, it may respond to the drugs used in the original treatment.

Major depressive disorder affects about 7% of adults, making it one of the most prevalent mental health conditions in the united states.Others may have tried many different options with few side effects, but no mg relief.This process has been installed at the vasgold project in kazakhstan, and the development, design, construction, and.If all relapses after a short remission, doctors will use other drugs.With multiple myeloma, almost all patients will experience a relapse or will see the disease become refractory.

This has a number of implications in the areas of training, education, research, and public health.Not all uncontrolled seizures are considered refractory or drug resistant.Individuals living with epilepsy experience seizures caused by irregular electrical signals in the brain.

28 Related Question Answers Found

Treatment of Resistant and Refractory Hypertension

Refractory hypertension is defined as uncontrolled blood ... Clinical inertia The failure to establish appropriate targets and escalate treatment to achieve treatment goals. Controlled resistant ...

Refractory Chronic Migraine: When Regular Treatments Don’t Work

But what about when treatment doesn’t work and your migraine persists for several days, not hours? Refractory migraine, also called intractable migraine, refers to migraine that is resistant to ...

Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature

A systematic review of the literature on additional treatments used in refractory and/or high-risk APS pregnancies was conducted. Records from February 2006 to October 2021 were retrieved from PubMed, ...

The Treatment of Super-refractory Status Epilepticus

The importance of treating the identifying cause is stressed. A protocol and flowchart for managing super-refractory status epilepticus is suggested. In view of the small number of published ...

Neuromodulation for treatment-refractory major depressive disorder

It may be used either as an add-on treatment to medication or as a stand-alone alternative for patients who decline or do not tolerate medication; it may be a good option for patients whose condition ...

The Progression of Treatment for Refractory Hypercholesterolemia: Focus on the Prospect of Gene Therapy

Patients with RH have early onset and higher risk of atherosclerotic cardiovascular disease (ASCVD) under insufficient treatment. Therefore, it is urgent to seek new therapies to maintain the blood ...

CMV coinfection in treatment refractory immune checkpoint inhibitor colitis

ICIs have been implicated in numerous adverse effects against healthy tissues. We present a case of a patient who developed treatment refractory checkpoint inhibitor colitis. Following colonoscopy, it ...

Treatment of Refractory Neurosarcoidosis with Cladribine

we attempted to treat this patient's refractory neurosarcoidosis similarly. 5 Base-line brain MRI scans were obtained; MRI scans of the spine were normal, as were the erythrocyte sedimentation ...

E-056 Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage

We review our experiences using percutaneous transluminal angioplasty (PTA) and intra-arterial (IA) verapamil infusion for treating medically refractory cases. Materials and methods Retrospective ...

Gilead: Kite's CAR T-cell Therapy Yescarta Gets EU Approval To Treat Relapsed Or Refractory FL

(GILD) announced Tuesday that its cell therapy company Kite's CAR T-cell therapy Yescarta (axicabtagene ciloleucel) received European marketing authorization from the European Commission to treat ...

Kite’s CAR T-cell Therapy Yescarta® Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Follicular Lymphoma

Kite, a Gilead Company (Nasdaq: GILD), today announces that the European Commission (EC) has approved its CAR T-cell therapy Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients ...

AN2 Therapeutics Initiates Pivotal Phase 2/3 Trial Evaluating Epetraborole for Treatment-Refractory MAC Lung Disease

AN2 is developing epetraborole as a once-daily, orally administered treatment with a novel mechanism of action for patients with NTM lung disease, with an initial focus on treatment-refractory MAC ...